Homocisteína en el paciente con diabetes mellitus
- 1 January 2004
- journal article
- abstracts
- Published by Elsevier BV in Medicina Clinica
- Vol. 122 (1), 27-32
- https://doi.org/10.1016/s0025-7753(04)74130-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide–derived end products in hyperhomocysteinemic subjectsAmerican Journal Of Medicine, 2001
- Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosisBlood, 2000
- Homocysteine stimulates the production and secretion of cholesterol in hepatic cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjectsMetabolism, 1998
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- S-adenosylmethionine synthesis: Molecular mechanisms and clinical implicationsPharmacology & Therapeutics, 1997
- The oxidant stress of hyperhomocyst(e)inemia.JCI Insight, 1996
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.Proceedings of the National Academy of Sciences, 1994
- Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Methionine metabolism in mammalsThe Journal of Nutritional Biochemistry, 1990